These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6136281)

  • 21. The release of endogenous dopamine from rat striatum during incubation in vitro.
    Snape BM; Holman RB
    J Neurosci Methods; 1985 Jun; 14(1):53-64. PubMed ID: 3875758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain.
    Holmes JC; Rutledge CO
    Biochem Pharmacol; 1976 Feb; 25(4):447-51. PubMed ID: 938573
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ; Yanai J; Iser C; Klawans H
    Neuropsychobiology; 1984; 11(2):94-7. PubMed ID: 6483167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the mechanism which mediates the effects of long-term administration of fencamfamine in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1989; 22(7):881-3. PubMed ID: 2576524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role if dopamine and norepinephrine uptake inhibition in mediating the central effects of d-amphetamine in vivo.
    Feigenbaum JJ; Yanai J; Blass RB
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):333-5. PubMed ID: 7071417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C; Scheel-Krüger J
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of reuptake inhibitors on dopamine release from the stalk-median eminence and posterior pituitary in vitro.
    Garris PA; Ben-Jonathan N
    Brain Res; 1991 Aug; 556(1):123-9. PubMed ID: 1933344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW; Johnson KM
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of fencamfamine on latent inhibition.
    Alves CR; Delucia R; Silva MT
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1089-93. PubMed ID: 12452530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
    Lamensdorf I; Porat S; Simantov R; Finberg JP
    Br J Pharmacol; 1999 Feb; 126(4):997-1002. PubMed ID: 10193780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of imipramine, nomifensine and d-amphetamine on type B monoamine oxidase, cyclic AMP phosphodiesterase and dopamine-beta-hydroxylase.
    Izumi H; Togashi O; Hayakari M; Hayashi S; Ozawa H
    Tohoku J Exp Med; 1976 Mar; 118(3):223-31. PubMed ID: 178070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.